Sequoia Capital

Sequoia Capital, founded in 1972 and based in Menlo Park, California, is a prominent venture capital firm that invests in early to growth stage companies across various sectors, including technology, healthcare, financial services, and consumer services. The firm specializes in supporting startups and emerging growth companies, typically investing between $100,000 and $1 million in seed companies, $1 million to $10 million in early ventures, and $10 million to $100 million in growth investments. Sequoia Capital operates globally, with a presence in regions such as Israel, China, and Southeast Asia, and has built a diverse portfolio that includes notable companies like Airbnb, Alibaba, and JD.com. The firm emphasizes a partnership approach with entrepreneurs, leveraging decades of experience to guide them from initial concept through to public offering and beyond.

Audrey Adeline

Analyst

Rohit Agarwal

Vice President / Principal

Rajan Anandan

Managing Director

Michelle Bailhe

Partner

Sumaiya Balbale

COO and Operating Partner

Anas Biad

Partner

Isaiah Boone

Partner

Roelof Botha

Partner

Romie Boyd

Partner

Rosemarie Boyd

Partner

Konstantine Buhler

Partner

David Cahn

Partner

Xi Cao

Partner, China

Vipin Chamakkala

Director, Customer Partnerships

Jiazhen Chen

Investor

Luzhou Chen

Investor

Josephine Chen

Partner

Sakshi Chopra

Managing Director

W. M. Coughran

Founder's Coach and Partner

Charlie Curnin

Partner

Long Do

Analyst

Joe Dobrenski

Partner of Human Capital

Helen Fan

Vice President

Shirley Feng

Managing Director

James Flynn

Partner

Caroline Fu

Vice President

Xiang Gao

Associate

Stacey Gerber

VP, Operations and Experiences

Mike Goguen

Partner

Christopher Graff

Partner, Global Equities

Wayne Guo

Managing Director

Kirstie Irmana

Analyst

Amit Jain

Managing Director

Pushpak Kedia

Associate

Pieter Kemps

Principal

Kais Khimji

Partner

Sunint Khurana

Analyst

Marie Klemchuk

Global CFO

Jess Lee

Partner

Jess Lee

Partner

Teng Lei

Associate

Douglas Leone

Global Managing Partner

Mei Li

Associate

Angie Shuyan Liu

Analyst

Luciana Lixandru

Partner

Xiaobo Lu

Partner, China

Alyssa Maharani

Analyst

Cornelius Menke

Partner

Dean Meyer

Partner

Ishaan Mittal

Managing Director

Abhishek Mohan

Principal

Che Pinjue

Partner, China

GV Ravishankar

Managing Director - India

Antara Raychaudhury

Analyst

Andrew Reed

General Partner

Lauren Reeder

Partner

George Robson

Partner

Haim Sadger

Partner, Israel

Bryan Schreier

Partner

Yoav Shaked

Partner, Israel

Prateek Sharma

VP

Neil Shen

Managing Partner

Shailendra Singh

Managing Director

Thomas Stephenson

Partner

Sam Sun

Partner

Glen Sun

Vice President, China

Johan Surani

Vice President

Jessica H. Tan

Analyst

Vedant Trivedi

Analyst

Aradhita Tuli

Analyst

Mike Vernal

Partner

Pavel Vyhnalek

Operating Partner

Jeff Wang

Managing Partner

Fred Wang

Managing Director

Cen Wang

Partner

Rock Wang

Managing Director

Kai Wang

Managing Director

Michael Xiong

Investor

Lynn Yang

Managing Director, China

Yu Yao

Managing Director

Stephanie Zhan

Partner

Skee Zhang

Managing Director

Qingsheng Zheng

Partner, China

Guo Zhenwei

Managing Director

Jiajia Zou

Managing Director

Past deals in Dental

Dezy

Series A in 2022
Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.

Miaoshou Doctor

Series F in 2021
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

Eighteeth

Series A in 2021
Eighteeth focuses on the research and production of dental instruments. Eighteeth has 14 product categories including endo motor, apex locator, ultrasonic scaler, curing light, X-Ray unit, intraoral sensor, intraoral scanner, and owns 110 authorized patents.

Zenyum

Series B in 2021
Zenyum Pte. Ltd., established in 2018 and based in Singapore, specializes in providing 3D-printed invisible braces for orthodontic treatment. The company aims to make dental care more accessible and affordable, ensuring that everyone can achieve a confident smile. By combining the expertise of professional dentists with advanced technology, Zenyum offers high-quality invisible braces that are delivered directly to customers' homes. The company emphasizes safety and simplicity in its clear teeth aligning devices, making dental routines more engaging for users. With a strong team of experienced entrepreneurs and orthodontists, Zenyum has secured significant funding from investors in the healthcare and tech sectors, positioning itself as a notable player in the dental care market.

Miaoshou Doctor

Series E in 2021
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

Dezy

Seed Round in 2021
Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.

Dizal Pharma

Venture Round in 2020
Dizal Pharmaceutical is a research-focused biotechnology company involved in the discovery, development, and commercialization of innovative medicines. The company specializes in creating first-in-class and best-in-class therapeutic solutions, emphasizing cutting-edge research and development. In addition to its drug development efforts, Dizal is also engaged in the production and sales of these innovative treatments, aiming to improve patient outcomes through advanced pharmaceutical solutions.

Miaoshou Doctor

Series D in 2020
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

Dentalink

Series C in 2020
Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.

Zenyum

Series A in 2019
Zenyum Pte. Ltd., established in 2018 and based in Singapore, specializes in providing 3D-printed invisible braces for orthodontic treatment. The company aims to make dental care more accessible and affordable, ensuring that everyone can achieve a confident smile. By combining the expertise of professional dentists with advanced technology, Zenyum offers high-quality invisible braces that are delivered directly to customers' homes. The company emphasizes safety and simplicity in its clear teeth aligning devices, making dental routines more engaging for users. With a strong team of experienced entrepreneurs and orthodontists, Zenyum has secured significant funding from investors in the healthcare and tech sectors, positioning itself as a notable player in the dental care market.

Miaoshou Doctor

Series C in 2019
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

Miaoshou Doctor

Series C in 2018
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

HealthEngine

Series C in 2017
HealthEngine Pty Ltd is an Australian online healthcare platform established in 2006 and headquartered in Perth. It provides a comprehensive online booking system that allows patients to find, book, and manage their appointments with various healthcare providers, including general practitioners, dentists, physiotherapists, chiropractors, and psychologists. The platform also features an online health directory to help users navigate the healthcare landscape, as well as HealthEngine recalls, which centralizes and manages patient recalls. Accessible via both a website and a smartphone app, HealthEngine serves over a million Australians monthly, facilitating millions of appointments each year. By connecting patients with healthcare professionals, the platform enhances the patient experience and allows practitioners to manage their appointments effectively.

B-Lite

Venture Round in 2015
B-Lite is provides lightweight breast implants. B-Lite implants reduce gravitational stress on the breast soft-tissue, as well as retain shape and form in the long term.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.